Conventional imaging is suboptimal at evaluating disease status in renal cell carcinoma (RCC) because of poor sensitivity. Furthermore, there is an unmet need for the treatment of metastatic RCC, both ...
Specificity of radiographic lymphadenopathy for lymph node metastasis in renal cell carcnioma. This is an ASCO Meeting Abstract from the 2015 Genitourinary Cancers Symposium. This abstract does not ...
Background: Advanced renal cell cancer (RCC) continues to have a poor overall prognosis despite new FDA-approved therapies. Although taxane-based therapies are generally ineffective in RCC, research ...
Many patients with localized node-negative renal cell carcinoma (RCC) are elderly with competing comorbidities. Their overall survival benefit after surgical treatment is unknown. We reviewed cases in ...
In a recent study published in Cancers, researchers explored the association between the human microbiome and improved renal cell carcinoma (RCC) outcomes. Study: A New Treatment Landscape for RCC: ...
Emerging treatments for renal cell carcinoma (RCC), including kinase inhibitors, checkpoint inhibitors, and combinations of these new agents, are improving outcomes for patients A need for biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results